This announcement is a separate document:
民生证券股份有限公司关于广州安必平医药科技股份有限公司2022年限制性股票激励计划作废部分已授予但尚未归属的限制性股票之独立财务顾问报告
Independent Financial Advisory Report of Minsheng Securities Co., Ltd. on restricted stocks granted in part of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.'s 2022 Restricted Stock Incentive Plan abolished but not yet owned
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.